Study Maps 832,505 Brain Immune Cells, Finds Alzheimer's Microglial State Tied to TREM2
Updated
Updated · BIOENGINEER.ORG · Aug 25
Study Maps 832,505 Brain Immune Cells, Finds Alzheimer's Microglial State Tied to TREM2
3 articles · Updated · BIOENGINEER.ORG · Aug 25
Summary
A Nature Genetics study profiled 832,505 myeloid cells from the prefrontal cortex of 1,607 donors and found a GPNMB-high microglial state that expands as Alzheimer's pathology worsens.
That subtype was enriched for polygenic Alzheimer's risk genes and showed higher phagocytic activity, linking inherited susceptibility to a specific immune program that may help clear damaged material.
Regulatory analysis identified MITF as a key factor maintaining the state, while cell-communication signals centered on APOE with SORL1 and TREM2 receptors.
TREM2 proved critical to the subtype's neuroprotective effect in human and mouse models, suggesting therapies may need to strengthen beneficial microglial programs rather than broadly suppress inflammation.
The findings add a large human map to growing evidence that brain immune-cell shifts in aging and dementia are central drivers of disease, not just byproducts of neuronal loss.